These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7053408)

  • 21. [Pharmacokinetics of drugs in the elderly].
    Petrin A
    Int J Clin Pharmacol; 1974 Mar; 9(2):157-9. PubMed ID: 4133294
    [No Abstract]   [Full Text] [Related]  

  • 22. Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?
    Wagner AK; Zhang F; Soumerai SB; Walker AM; Gurwitz JH; Glynn RJ; Ross-Degnan D
    Arch Intern Med; 2004 Jul; 164(14):1567-72. PubMed ID: 15277291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Benzodiazepine use in the elderly: the EVA Study].
    Lechevallier N; Fourrier A; Berr C
    Rev Epidemiol Sante Publique; 2003 Jun; 51(3):317-26. PubMed ID: 13130212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of age and sex on human drug metabolism.
    O'Malley K; Crooks J; Duke E; Stevenson IH
    Br Med J; 1971 Sep; 3(5775):607-9. PubMed ID: 5569980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of aging on antipyrine clearance: predictive factors of metabolizing capacity.
    Jorquera F; Almar MM; Pozuelo M; Sansegundo D; González-Sastre M; González-Gallego J
    J Clin Pharmacol; 1995 Sep; 35(9):895-901. PubMed ID: 8786249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxazepam kinetics: effects of age and sex.
    Greenblatt DJ; Divoll M; Harmatz JS; Shader RI
    J Pharmacol Exp Ther; 1980 Oct; 215(1):86-91. PubMed ID: 7452494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors influencing antipyrine elimination.
    Stevenson IH
    Br J Clin Pharmacol; 1977 Jun; 4(3):261-5. PubMed ID: 332216
    [No Abstract]   [Full Text] [Related]  

  • 28. Antipyrine kinetics in cannabis smokers.
    Uppal R; Garg SK; Sharma PR; Varma VK; Chaudhury RR
    Br J Clin Pharmacol; 1981 May; 11(5):522-3. PubMed ID: 7272166
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of age and smoking upon antipyrine metabolism.
    Mucklow JC; Fraser HS
    Br J Clin Pharmacol; 1980 Jun; 9(6):613-4. PubMed ID: 7387818
    [No Abstract]   [Full Text] [Related]  

  • 30. Sleep disorders and aging.
    Rains VS; Ditzler TF
    N Engl J Med; 1992 Apr; 326(14):956-7. PubMed ID: 1542355
    [No Abstract]   [Full Text] [Related]  

  • 31. Phenazone (antipyrine) metabolism and distribution in young and elderly adults.
    Liddell DE; Williams FM; Briant RH
    Clin Exp Pharmacol Physiol; 1975; 2(6):481-7. PubMed ID: 1236602
    [No Abstract]   [Full Text] [Related]  

  • 32. Environmental factors affecting antipyrine metabolism in London factory and office workers.
    Fraser HS; Mucklow JC; Bulpitt CJ; Kahn C; Mould G; Dollery CT
    Br J Clin Pharmacol; 1979 Mar; 7(3):237-43. PubMed ID: 427001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life.
    Herings RM; Stricker BH; de Boer A; Bakker A; Sturmans F
    Arch Intern Med; 1995 Sep; 155(16):1801-7. PubMed ID: 7654115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antipyrine elimination in critically ill patients.
    Mirvis L; Buchanan N; Eyberg C
    Intensive Care Med; 1979 May; 5(2):69-71. PubMed ID: 458036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of sulfamerazine and antipyrine in neonatal and young lambs.
    De Backer P; Belpaire FM; Bogaert MG; Debackere M
    Am J Vet Res; 1982 Oct; 43(10):1744-51. PubMed ID: 7149373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J; Alsar Ortiz MJ
    Rev Clin Esp; 1993 Jun; 193(2):60-3. PubMed ID: 8341815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and metabolism of antipyrine (phenazone) after intravenous and oral administration.
    Eichelbaum M; Ochs HR; Roberts G; Somogyi A
    Arzneimittelforschung; 1982; 32(5):575-8. PubMed ID: 7201837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic interaction of fluconazole and zidovudine in HIV-positive patients.
    Brockmeyer NH; Tillmann I; Mertins L; Barthel B; Goos M
    Eur J Med Res; 1997 Sep; 2(9):377-83. PubMed ID: 9300934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetics of phenazone as an indicator of the metabolic capacity of the liver in patients with hyperthyroidism].
    Orzechowska-Juzwenko K; Bolanowski M; Gruszka S; Szymczak J
    Pol Tyg Lek; 1983 May 16-23; 38(20-21):643-5. PubMed ID: 6647129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.